Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
"Painful foot conditions, such as osteoarthritis, calluses, bunions, hammertoes and diabetes complications ... are helping patients restore functionality and get back to normal faster than ever before ...
An innovative New South Wales government funded statewide Cannabis Medicines Advisory Service (CMAS) operated between January 2018 and June 2022. The service provided comprehensive patient-specific ...